Organization

Instituto de Estudios de Mastocitosis de Castilla La Mancha

1 poster

Poster

PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy